Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Prenatal treatment improves cystic fibrosis

April 3, 2019

FDA approves Duaklir for maintenance treatment of COPD

April 1, 2019

Chiesi Farmaceutici presents ROCK1 and ROCK2 inhibitors

April 1, 2019

Potent new glucocorticoid reverses severe steroid-resistant asthma

April 1, 2019

Cathepsin S has a pathogenic role in CF and smoke-induced COPD: a potential target for lung diseases

March 29, 2019

Proteostasis reports data set on CFTR modulator triple combination therapy

March 25, 2019

Knopp Biosciences enters collaboration to initiate phase II trial of dexpramipexole

March 21, 2019

Workaround may be mutation agnostic treatment for cystic fibrosis

March 18, 2019

Runx2 as a new target in chronic rhinosinusitis with neo-osteogenesis

March 14, 2019

CARD9 pathway as a potential therapeutic target in allergic airway disease

March 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...